Novel motif:108: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif108_AACKSARM
|novel_motifs_human_sample_pval=11376-118A8_11051;0.439259,11327-117E4_11969;0.147962,11473-119C6_11054;0.491356,11474-119C7_12067;0.15...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:07, 9 September 2013
name: | motif108_AACKSARM |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0018874 | benzoate metabolic process | 2.933810e-9 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 8.425299e-9 |
GO:0043922 | negative regulation by host of viral transcription | 8.436142e-9 |
GO:0043420 | anthranilate metabolic process | 8.857040e-9 |
GO:0034516 | response to vitamin B6 | 8.857040e-9 |
GO:0019442 | tryptophan catabolic process to acetyl-CoA | 3.170047e-8 |
GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 8.848837e-8 |
GO:0065004 | protein-DNA complex assembly | 1.123132e-7 |
GO:0032897 | negative regulation of viral transcription | 2.068598e-7 |
GO:0051383 | kinetochore organization | 4.008417e-7 |
GO:0051573 | negative regulation of histone H3-K9 methylation | 4.115481e-7 |
GO:0034014 | response to triglyceride | 4.727942e-7 |
GO:0035404 | histone-serine phosphorylation | 6.836239e-7 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 1.338122e-6 |
GO:0031572 | G2/M transition DNA damage checkpoint | 1.385736e-6 |
GO:0019805 | quinolinate biosynthetic process | 1.639689e-6 |
GO:0031576 | G2/M transition checkpoint | 2.234388e-6 |
GO:0051004 | regulation of lipoprotein lipase activity | 2.248789e-6 |
GO:0006335 | DNA replication-dependent nucleosome assembly | 2.277698e-6 |
GO:0046874 | quinolinate metabolic process | 2.386502e-6 |
GO:0071824 | protein-DNA complex subunit organization | 2.965787e-6 |
GO:0031055 | chromatin remodeling at centromere | 3.241507e-6 |
GO:0007249 | I-kappaB kinase/NF-kappaB cascade | 3.273155e-6 |
GO:2000121 | regulation of removal of superoxide radicals | 4.554568e-6 |
GO:0072337 | modified amino acid transport | 4.591976e-6 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 5.152124e-6 |
GO:0033194 | response to hydroperoxide | 5.153371e-6 |
GO:0030683 | evasion by virus of host immune response | 5.313297e-6 |
GO:0046687 | response to chromate | 5.370607e-6 |
GO:0033986 | response to methanol | 5.370607e-6 |
GO:2000648 | positive regulation of stem cell proliferation | 6.774613e-6 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 7.193655e-6 |
GO:0016572 | histone phosphorylation | 7.914492e-6 |
GO:0051382 | kinetochore assembly | 8.851685e-6 |
GO:0071780 | mitotic cell cycle G2/M transition checkpoint | 9.785088e-6 |
GO:0034470 | ncRNA processing | 1.040706e-5 |
GO:0007095 | mitotic cell cycle G2/M transition DNA damage checkpoint | 1.045255e-5 |
GO:0006214 | thymidine catabolic process | 1.104801e-5 |
GO:0046104 | thymidine metabolic process | 1.189663e-5 |
GO:0085020 | protein K6-linked ubiquitination | 1.893656e-5 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 1.918426e-5 |
GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining | 2.211952e-5 |
GO:2000685 | positive regulation of cellular response to X-ray | 2.211952e-5 |
GO:2001038 | regulation of cellular response to drug | 2.211952e-5 |
GO:0003131 | mesodermal-endodermal cell signaling | 2.211952e-5 |
GO:0031052 | chromosome breakage | 2.211952e-5 |
GO:0035978 | histone H2A-S139 phosphorylation | 2.211952e-5 |
GO:2000602 | regulation of interphase of mitotic cell cycle | 2.265959e-5 |
GO:0034723 | DNA replication-dependent nucleosome organization | 2.688059e-5 |
GO:0006145 | purine base catabolic process | 2.723792e-5 |
GO:0090130 | tissue migration | 2.972133e-5 |
GO:0001832 | blastocyst growth | 3.263281e-5 |
GO:0043486 | histone exchange | 3.283975e-5 |
GO:0090322 | regulation of superoxide metabolic process | 3.732282e-5 |
GO:0006212 | uracil catabolic process | 3.738746e-5 |
GO:0006210 | thymine catabolic process | 3.738746e-5 |
GO:0021528 | commissural neuron differentiation in spinal cord | 3.991160e-5 |
GO:2000779 | regulation of double-strand break repair | 4.018974e-5 |
GO:0033566 | gamma-tubulin complex localization | 4.070774e-5 |
GO:0051707 | response to other organism | 4.123590e-5 |
GO:0046339 | diacylglycerol metabolic process | 4.379527e-5 |
GO:0031497 | chromatin assembly | 4.489429e-5 |
GO:0008033 | tRNA processing | 5.286553e-5 |
GO:0051532 | regulation of NFAT protein import into nucleus | 5.354404e-5 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 6.063833e-5 |
GO:0046426 | negative regulation of JAK-STAT cascade | 6.228633e-5 |
GO:0043921 | modulation by host of viral transcription | 6.266524e-5 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 6.357789e-5 |
GO:0035026 | leading edge cell differentiation | 7.578461e-5 |
GO:0045872 | positive regulation of rhodopsin gene expression | 8.312482e-5 |
GO:0034340 | response to type I interferon | 8.957001e-5 |
GO:0060443 | mammary gland morphogenesis | 9.376430e-5 |
GO:0060337 | type I interferon-mediated signaling pathway | 9.760131e-5 |
GO:0035307 | positive regulation of protein dephosphorylation | 9.933710e-5 |
GO:0006366 | transcription from RNA polymerase II promoter | 9.995561e-5 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1.019639e-4 |
GO:0035988 | chondrocyte proliferation | 1.044890e-4 |
GO:0009449 | gamma-aminobutyric acid biosynthetic process | 1.073169e-4 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.102874e-4 |
GO:0002551 | mast cell chemotaxis | 1.123197e-4 |
GO:0048662 | negative regulation of smooth muscle cell proliferation | 1.128596e-4 |
GO:0010631 | epithelial cell migration | 1.138323e-4 |
GO:0010713 | negative regulation of collagen metabolic process | 1.218540e-4 |
GO:0010288 | response to lead ion | 1.249399e-4 |
GO:0009607 | response to biotic stimulus | 1.283059e-4 |
GO:0046951 | ketone body biosynthetic process | 1.386311e-4 |
GO:0019859 | thymine metabolic process | 1.386311e-4 |
GO:0051089 | constitutive protein ectodomain proteolysis | 1.400601e-4 |
GO:0033617 | mitochondrial respiratory chain complex IV assembly | 1.400601e-4 |
GO:0034660 | ncRNA metabolic process | 1.414174e-4 |
GO:0010811 | positive regulation of cell-substrate adhesion | 1.442325e-4 |
GO:0034508 | centromere complex assembly | 1.481582e-4 |
GO:0000279 | M phase | 1.485812e-4 |
GO:0050955 | thermoception | 1.494717e-4 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 1.545782e-4 |
GO:0090304 | nucleic acid metabolic process | 1.546563e-4 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 1.552959e-4 |
GO:0035306 | positive regulation of dephosphorylation | 1.561589e-4 |
GO:0042306 | regulation of protein import into nucleus | 1.675816e-4 |
GO:0034377 | plasma lipoprotein particle assembly | 1.698680e-4 |
GO:0006333 | chromatin assembly or disassembly | 1.811975e-4 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | 1.846651e-4 |
GO:0035518 | histone H2A monoubiquitination | 1.848125e-4 |
GO:0033522 | histone H2A ubiquitination | 1.889918e-4 |
GO:0042633 | hair cycle | 1.923543e-4 |
GO:0006689 | ganglioside catabolic process | 1.988271e-4 |
GO:0016180 | snRNA processing | 2.011508e-4 |
GO:0060312 | regulation of blood vessel remodeling | 2.020293e-4 |
GO:0051365 | cellular response to potassium ion starvation | 2.020293e-4 |
GO:0009615 | response to virus | 2.041530e-4 |
GO:0006207 | 'de novo' pyrimidine base biosynthetic process | 2.072356e-4 |
GO:0046716 | muscle cell homeostasis | 2.161700e-4 |
GO:0045116 | protein neddylation | 2.170631e-4 |
GO:0035304 | regulation of protein dephosphorylation | 2.250967e-4 |
GO:0046125 | pyrimidine deoxyribonucleoside metabolic process | 2.303816e-4 |
GO:2000620 | positive regulation of histone H4-K16 acetylation | 2.355850e-4 |
GO:0070512 | positive regulation of histone H4-K20 methylation | 2.355850e-4 |
GO:2000617 | positive regulation of histone H3-K9 acetylation | 2.355850e-4 |
GO:0090402 | oncogene-induced senescence | 2.400947e-4 |
GO:0071156 | regulation of cell cycle arrest | 2.456925e-4 |
GO:0007064 | mitotic sister chromatid cohesion | 2.519437e-4 |
GO:0006352 | transcription initiation, DNA-dependent | 2.543264e-4 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 2.549981e-4 |
GO:0030212 | hyaluronan metabolic process | 2.611998e-4 |
GO:0045199 | maintenance of epithelial cell apical/basal polarity | 2.660589e-4 |
GO:0006334 | nucleosome assembly | 2.703358e-4 |
GO:0006638 | neutral lipid metabolic process | 2.705084e-4 |
GO:0008202 | steroid metabolic process | 2.711524e-4 |
GO:0016070 | RNA metabolic process | 2.735693e-4 |
GO:0044088 | regulation of vacuole organization | 2.806790e-4 |
GO:0032288 | myelin assembly | 2.926565e-4 |
GO:2000786 | positive regulation of autophagic vacuole assembly | 3.124263e-4 |
GO:0050916 | sensory perception of sweet taste | 3.228819e-4 |
GO:0090230 | regulation of centromere complex assembly | 3.228819e-4 |
GO:2000036 | regulation of stem cell maintenance | 3.258911e-4 |
GO:0072091 | regulation of stem cell proliferation | 3.389884e-4 |
GO:0045869 | negative regulation of retroviral genome replication | 3.409651e-4 |
GO:0045608 | negative regulation of auditory receptor cell differentiation | 3.436060e-4 |
GO:0045046 | protein import into peroxisome membrane | 3.442698e-4 |
GO:0010467 | gene expression | 3.486141e-4 |
GO:0046822 | regulation of nucleocytoplasmic transport | 3.544222e-4 |
GO:0035441 | cell migration involved in vasculogenesis | 3.577138e-4 |
GO:0034589 | hydroxyproline transport | 3.577138e-4 |
GO:0015826 | threonine transport | 3.577138e-4 |
GO:0015911 | plasma membrane long-chain fatty acid transport | 3.718895e-4 |
GO:0010624 | regulation of Schwann cell proliferation | 3.725558e-4 |
GO:0042159 | lipoprotein catabolic process | 3.853727e-4 |
GO:0006639 | acylglycerol metabolic process | 3.917214e-4 |
GO:0050672 | negative regulation of lymphocyte proliferation | 3.972415e-4 |
GO:0070664 | negative regulation of leukocyte proliferation | 4.000736e-4 |
GO:0016073 | snRNA metabolic process | 4.007534e-4 |
GO:0000080 | G1 phase of mitotic cell cycle | 4.061111e-4 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 4.141553e-4 |
GO:0034381 | plasma lipoprotein particle clearance | 4.149761e-4 |
GO:0071930 | negative regulation of transcription involved in G1/S phase of mitotic cell cycle | 4.166889e-4 |
GO:0055088 | lipid homeostasis | 4.201633e-4 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 4.250558e-4 |
GO:0015804 | neutral amino acid transport | 4.280019e-4 |
GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process | 4.404087e-4 |
GO:0010886 | positive regulation of cholesterol storage | 4.478251e-4 |
GO:0042990 | regulation of transcription factor import into nucleus | 4.523439e-4 |
GO:0090005 | negative regulation of establishment of protein localization in plasma membrane | 4.708361e-4 |
GO:0030423 | targeting of mRNA for destruction involved in RNA interference | 4.750032e-4 |
GO:0045738 | negative regulation of DNA repair | 4.768871e-4 |
GO:0051318 | G1 phase | 4.876840e-4 |
GO:0072526 | pyridine-containing compound catabolic process | 4.882275e-4 |
GO:0032290 | peripheral nervous system myelin formation | 4.882275e-4 |
GO:0071335 | hair follicle cell proliferation | 4.882275e-4 |
GO:0042632 | cholesterol homeostasis | 4.898162e-4 |
GO:0016557 | peroxisome membrane biogenesis | 5.216027e-4 |
GO:0043129 | surfactant homeostasis | 5.226146e-4 |
GO:0016598 | protein arginylation | 5.237858e-4 |
GO:0030518 | steroid hormone receptor signaling pathway | 5.371348e-4 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 5.376775e-4 |
GO:0043526 | neuroprotection | 5.431856e-4 |
GO:0034379 | very-low-density lipoprotein particle assembly | 5.534464e-4 |
GO:0031054 | pre-miRNA processing | 5.827677e-4 |
GO:0006493 | protein O-linked glycosylation | 5.835018e-4 |
GO:0006651 | diacylglycerol biosynthetic process | 5.909100e-4 |
GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein | 5.965422e-4 |
GO:0031134 | sister chromatid biorientation | 6.025557e-4 |
GO:0000212 | meiotic spindle organization | 6.093097e-4 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 6.128995e-4 |
GO:0034754 | cellular hormone metabolic process | 6.136849e-4 |
GO:0001942 | hair follicle development | 6.291455e-4 |
GO:0002262 | myeloid cell homeostasis | 6.308694e-4 |
GO:0010721 | negative regulation of cell development | 6.326767e-4 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 6.347294e-4 |
GO:0007638 | mechanosensory behavior | 6.694407e-4 |
GO:0000075 | cell cycle checkpoint | 7.047567e-4 |
GO:0001893 | maternal placenta development | 7.257660e-4 |
GO:0045607 | regulation of auditory receptor cell differentiation | 7.335037e-4 |
GO:0032486 | Rap protein signal transduction | 7.335037e-4 |
GO:0051704 | multi-organism process | 7.469478e-4 |
GO:0045069 | regulation of viral genome replication | 7.500428e-4 |
GO:0071447 | cellular response to hydroperoxide | 7.719318e-4 |
GO:0009129 | pyrimidine nucleoside monophosphate metabolic process | 8.217563e-4 |
GO:0000236 | mitotic prometaphase | 8.474302e-4 |
GO:0097045 | phosphatidylserine exposure on blood platelet | 8.540515e-4 |
GO:0071670 | smooth muscle cell chemotaxis | 8.540515e-4 |
GO:0060981 | cell migration involved in coronary angiogenesis | 8.540515e-4 |
GO:0043170 | macromolecule metabolic process | 8.631258e-4 |
GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 8.841799e-4 |
GO:0032814 | regulation of natural killer cell activation | 9.082463e-4 |
GO:0009435 | NAD biosynthetic process | 9.121431e-4 |
GO:0043666 | regulation of phosphoprotein phosphatase activity | 9.206719e-4 |
GO:0030889 | negative regulation of B cell proliferation | 9.274277e-4 |
GO:0051320 | S phase | 9.490032e-4 |
GO:0008152 | metabolic process | 9.775281e-4 |
GO:0051403 | stress-activated MAPK cascade | 1.018769e-3 |
GO:0007565 | female pregnancy | 1.057960e-3 |
GO:2000772 | regulation of cellular senescence | 1.076197e-3 |
GO:0060253 | negative regulation of glial cell proliferation | 1.088545e-3 |
GO:0007093 | mitotic cell cycle checkpoint | 1.089902e-3 |
GO:0046683 | response to organophosphorus | 1.094895e-3 |
GO:0032496 | response to lipopolysaccharide | 1.107708e-3 |
GO:0015825 | L-serine transport | 1.117843e-3 |
GO:0006084 | acetyl-CoA metabolic process | 1.118125e-3 |
GO:0002384 | hepatic immune response | 1.121551e-3 |
GO:0022403 | cell cycle phase | 1.130593e-3 |
GO:0046112 | nucleobase biosynthetic process | 1.188040e-3 |
GO:0007250 | activation of NF-kappaB-inducing kinase activity | 1.242019e-3 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 1.277082e-3 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 1.287552e-3 |
GO:0032581 | ER-dependent peroxisome organization | 1.314930e-3 |
GO:0035572 | N-terminal peptidyl-serine dimethylation | 1.332885e-3 |
GO:0035573 | N-terminal peptidyl-serine trimethylation | 1.332885e-3 |
GO:0018016 | N-terminal peptidyl-proline dimethylation | 1.332885e-3 |
GO:0018012 | N-terminal peptidyl-alanine trimethylation | 1.332885e-3 |
GO:0060968 | regulation of gene silencing | 1.428211e-3 |
GO:0003017 | lymph circulation | 1.450245e-3 |
GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein | 1.467773e-3 |
GO:0021555 | midbrain-hindbrain boundary morphogenesis | 1.468635e-3 |
GO:0071221 | cellular response to bacterial lipopeptide | 1.472937e-3 |
GO:0033157 | regulation of intracellular protein transport | 1.487764e-3 |
GO:0018209 | peptidyl-serine modification | 1.503845e-3 |
GO:0008636 | activation of caspase activity by protein phosphorylation | 1.531181e-3 |
GO:0035409 | histone H3-Y41 phosphorylation | 1.531181e-3 |
GO:0006313 | transposition, DNA-mediated | 1.531181e-3 |
GO:2000334 | positive regulation of blood microparticle formation | 1.533593e-3 |
GO:0032966 | negative regulation of collagen biosynthetic process | 1.593349e-3 |
GO:0060251 | regulation of glial cell proliferation | 1.595662e-3 |
GO:0044111 | development involved in symbiotic interaction | 1.595946e-3 |
GO:0019089 | transmission of virus | 1.595946e-3 |
GO:0010768 | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage | 1.595946e-3 |
GO:0006662 | glycerol ether metabolic process | 1.612674e-3 |
GO:0043523 | regulation of neuron apoptosis | 1.621399e-3 |
GO:0042976 | activation of Janus kinase activity | 1.640928e-3 |
GO:0035117 | embryonic arm morphogenesis | 1.647233e-3 |
GO:0042594 | response to starvation | 1.675493e-3 |
GO:0006139 | nucleobase-containing compound metabolic process | 1.712919e-3 |
GO:0071479 | cellular response to ionizing radiation | 1.729305e-3 |
GO:0031507 | heterochromatin formation | 1.744446e-3 |
GO:0035644 | phosphoanandamide dephosphorylation | 1.751830e-3 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 1.751830e-3 |
GO:0007113 | endomitotic cell cycle | 1.751830e-3 |
GO:0001519 | peptide amidation | 1.751830e-3 |
GO:2001022 | positive regulation of response to DNA damage stimulus | 1.779134e-3 |
GO:0002237 | response to molecule of bacterial origin | 1.799498e-3 |
GO:0048681 | negative regulation of axon regeneration | 1.865186e-3 |
GO:0042997 | negative regulation of Golgi to plasma membrane protein transport | 1.876563e-3 |
GO:0042538 | hyperosmotic salinity response | 1.876563e-3 |
GO:0060977 | coronary vasculature morphogenesis | 1.883223e-3 |
GO:0034629 | cellular protein complex localization | 1.885512e-3 |
GO:0018105 | peptidyl-serine phosphorylation | 1.892841e-3 |
GO:0042308 | negative regulation of protein import into nucleus | 1.904181e-3 |
GO:0035308 | negative regulation of protein dephosphorylation | 1.939486e-3 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 1.939486e-3 |
GO:0031223 | auditory behavior | 1.985258e-3 |
GO:0042992 | negative regulation of transcription factor import into nucleus | 2.002045e-3 |
GO:0014070 | response to organic cyclic compound | 2.023288e-3 |
GO:0030522 | intracellular receptor mediated signaling pathway | 2.040161e-3 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 2.063828e-3 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 2.099233e-3 |
GO:0051851 | modification by host of symbiont morphology or physiology | 2.108682e-3 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 2.125576e-3 |
GO:0070173 | regulation of enamel mineralization | 2.125576e-3 |
GO:0010897 | negative regulation of triglyceride catabolic process | 2.125576e-3 |
GO:0001833 | inner cell mass cell proliferation | 2.132172e-3 |
GO:0006537 | glutamate biosynthetic process | 2.153095e-3 |
GO:0006399 | tRNA metabolic process | 2.209662e-3 |
GO:0070534 | protein K63-linked ubiquitination | 2.280786e-3 |
GO:0055096 | low-density lipoprotein particle mediated signaling | 2.284914e-3 |
GO:0007468 | regulation of rhodopsin gene expression | 2.289124e-3 |
GO:0034341 | response to interferon-gamma | 2.303994e-3 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 2.315004e-3 |
GO:0035090 | maintenance of apical/basal cell polarity | 2.317035e-3 |
GO:0060575 | intestinal epithelial cell differentiation | 2.327068e-3 |
GO:0006742 | NADP catabolic process | 2.394274e-3 |
GO:0006914 | autophagy | 2.480450e-3 |
GO:0006642 | triglyceride mobilization | 2.498112e-3 |
GO:0046121 | deoxyribonucleoside catabolic process | 2.506296e-3 |
GO:2000242 | negative regulation of reproductive process | 2.526543e-3 |
GO:0001780 | neutrophil homeostasis | 2.563826e-3 |
GO:0015824 | proline transport | 2.581967e-3 |
GO:0042977 | activation of JAK2 kinase activity | 2.590650e-3 |
GO:0030174 | regulation of DNA-dependent DNA replication initiation | 2.623155e-3 |
GO:0048263 | determination of dorsal identity | 2.623155e-3 |
GO:0022002 | negative regulation of anterior neural cell fate commitment of the neural plate by Wnt receptor signaling pathway | 2.623155e-3 |
GO:2000774 | positive regulation of cellular senescence | 2.642910e-3 |
GO:0035986 | senescence-associated heterochromatin focus formation | 2.642910e-3 |
GO:0050702 | interleukin-1 beta secretion | 2.642910e-3 |
GO:0032386 | regulation of intracellular transport | 2.653251e-3 |
GO:0006396 | RNA processing | 2.671764e-3 |
GO:0015031 | protein transport | 2.710966e-3 |
GO:0042694 | muscle cell fate specification | 2.769026e-3 |
GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 2.789431e-3 |
GO:0034383 | low-density lipoprotein particle clearance | 2.810939e-3 |
GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.835080e-3 |
GO:0060876 | semicircular canal formation | 2.887086e-3 |
GO:0006189 | 'de novo' IMP biosynthetic process | 2.887086e-3 |
GO:2000773 | negative regulation of cellular senescence | 2.906455e-3 |
GO:0043697 | cell dedifferentiation | 2.906455e-3 |
GO:0097006 | regulation of plasma lipoprotein particle levels | 2.927451e-3 |
GO:0014002 | astrocyte development | 2.993763e-3 |
GO:0050951 | sensory perception of temperature stimulus | 3.024479e-3 |
GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein | 3.024479e-3 |
GO:0014037 | Schwann cell differentiation | 3.064700e-3 |
GO:0035881 | amacrine cell differentiation | 3.069668e-3 |
GO:0010626 | negative regulation of Schwann cell proliferation | 3.107089e-3 |
GO:0008203 | cholesterol metabolic process | 3.150783e-3 |
GO:0048285 | organelle fission | 3.266318e-3 |
GO:0005976 | polysaccharide metabolic process | 3.275730e-3 |
GO:0071481 | cellular response to X-ray | 3.358202e-3 |
GO:0060100 | positive regulation of phagocytosis, engulfment | 3.358202e-3 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 3.420472e-3 |
GO:0015807 | L-amino acid transport | 3.467996e-3 |
GO:0032651 | regulation of interleukin-1 beta production | 3.505485e-3 |
GO:0046950 | cellular ketone body metabolic process | 3.516579e-3 |
GO:0071459 | protein localization to chromosome, centromeric region | 3.604821e-3 |
GO:0042908 | xenobiotic transport | 3.604821e-3 |
GO:0051702 | interaction with symbiont | 3.635335e-3 |
GO:0050901 | leukocyte tethering or rolling | 3.678988e-3 |
GO:0060659 | nipple sheath formation | 3.720155e-3 |
GO:0060649 | mammary gland bud elongation | 3.720155e-3 |
GO:0018023 | peptidyl-lysine trimethylation | 3.720155e-3 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 3.734749e-3 |
GO:0090209 | negative regulation of triglyceride metabolic process | 3.737312e-3 |
GO:0045017 | glycerolipid biosynthetic process | 3.765840e-3 |
GO:0006222 | UMP biosynthetic process | 3.767749e-3 |
GO:0031623 | receptor internalization | 3.778193e-3 |
GO:0050847 | progesterone receptor signaling pathway | 3.799582e-3 |
GO:0005981 | regulation of glycogen catabolic process | 3.799582e-3 |
GO:2000077 | negative regulation of type B pancreatic cell development | 3.845229e-3 |
GO:0045059 | positive thymic T cell selection | 3.899605e-3 |
GO:0019695 | choline metabolic process | 3.915871e-3 |
GO:0051412 | response to corticosterone stimulus | 3.920429e-3 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 3.968282e-3 |
GO:0006807 | nitrogen compound metabolic process | 3.990026e-3 |
GO:0043622 | cortical microtubule organization | 3.997508e-3 |
GO:0030103 | vasopressin secretion | 3.997508e-3 |
GO:0034728 | nucleosome organization | 4.012137e-3 |
GO:0055069 | zinc ion homeostasis | 4.027433e-3 |
GO:0006898 | receptor-mediated endocytosis | 4.079455e-3 |
GO:0019441 | tryptophan catabolic process to kynurenine | 4.080248e-3 |
GO:0043950 | positive regulation of cAMP-mediated signaling | 4.082301e-3 |
GO:0046600 | negative regulation of centriole replication | 4.082301e-3 |
GO:0045655 | regulation of monocyte differentiation | 4.092335e-3 |
GO:0046464 | acylglycerol catabolic process | 4.141027e-3 |
GO:0060056 | mammary gland involution | 4.142822e-3 |
GO:0032488 | Cdc42 protein signal transduction | 4.143079e-3 |
GO:0014044 | Schwann cell development | 4.184335e-3 |
GO:0042953 | lipoprotein transport | 4.207887e-3 |
GO:0045204 | MAPK export from nucleus | 4.254044e-3 |
GO:0045209 | MAPK phosphatase export from nucleus, leptomycin B sensitive | 4.254044e-3 |
GO:0007263 | nitric oxide mediated signal transduction | 4.264962e-3 |
GO:0006513 | protein monoubiquitination | 4.306504e-3 |
GO:0090311 | regulation of protein deacetylation | 4.331981e-3 |
GO:0015871 | choline transport | 4.381866e-3 |
GO:0043949 | regulation of cAMP-mediated signaling | 4.386657e-3 |
GO:0042512 | negative regulation of tyrosine phosphorylation of Stat1 protein | 4.395926e-3 |
GO:0021955 | central nervous system neuron axonogenesis | 4.438095e-3 |
GO:0042036 | negative regulation of cytokine biosynthetic process | 4.514072e-3 |
GO:0060022 | hard palate development | 4.543806e-3 |
GO:0006310 | DNA recombination | 4.604588e-3 |
GO:0000725 | recombinational repair | 4.684660e-3 |
GO:0044260 | cellular macromolecule metabolic process | 4.693992e-3 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 4.698650e-3 |
GO:0060730 | regulation of intestinal epithelial structure maintenance | 4.698650e-3 |
GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein | 4.698650e-3 |
GO:0043308 | eosinophil degranulation | 4.730026e-3 |
GO:0009239 | enterobactin biosynthetic process | 4.730026e-3 |
GO:0032802 | low-density lipoprotein particle receptor catabolic process | 4.730026e-3 |
GO:0045088 | regulation of innate immune response | 4.742712e-3 |
GO:0032774 | RNA biosynthetic process | 4.839704e-3 |
GO:0008380 | RNA splicing | 4.878567e-3 |
GO:0032925 | regulation of activin receptor signaling pathway | 4.885375e-3 |
GO:0019433 | triglyceride catabolic process | 4.927984e-3 |
GO:0048203 | vesicle targeting, trans-Golgi to endosome | 5.031242e-3 |
GO:0045355 | negative regulation of interferon-alpha biosynthetic process | 5.031242e-3 |
GO:0046358 | butyrate biosynthetic process | 5.031242e-3 |
GO:0070563 | negative regulation of vitamin D receptor signaling pathway | 5.039337e-3 |
GO:0050968 | detection of chemical stimulus involved in sensory perception of pain | 5.039337e-3 |
GO:0035921 | desmosome disassembly | 5.039337e-3 |
GO:0032782 | bile acid secretion | 5.039337e-3 |
GO:0006351 | transcription, DNA-dependent | 5.089452e-3 |
GO:0048853 | forebrain morphogenesis | 5.096955e-3 |
GO:0070375 | BMK cascade | 5.144391e-3 |
GO:0022402 | cell cycle process | 5.177011e-3 |
GO:0060409 | positive regulation of acetylcholine metabolic process | 5.257125e-3 |
GO:0071379 | cellular response to prostaglandin stimulus | 5.281209e-3 |
GO:0006014 | D-ribose metabolic process | 5.281209e-3 |
GO:0002331 | pre-B cell allelic exclusion | 5.290017e-3 |
GO:0015760 | glucose-6-phosphate transport | 5.291222e-3 |
GO:0006536 | glutamate metabolic process | 5.292659e-3 |
GO:0006953 | acute-phase response | 5.389830e-3 |
GO:0010390 | histone monoubiquitination | 5.470125e-3 |
GO:0032816 | positive regulation of natural killer cell activation | 5.678709e-3 |
GO:0009074 | aromatic amino acid family catabolic process | 5.692973e-3 |
GO:0006306 | DNA methylation | 5.726455e-3 |
GO:0051790 | short-chain fatty acid biosynthetic process | 5.786159e-3 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 5.786159e-3 |
GO:0044238 | primary metabolic process | 5.833158e-3 |
GO:0043112 | receptor metabolic process | 5.910496e-3 |
GO:0046519 | sphingoid metabolic process | 5.932382e-3 |
GO:0034134 | toll-like receptor 2 signaling pathway | 5.980784e-3 |
GO:0034130 | toll-like receptor 1 signaling pathway | 5.980784e-3 |
GO:0032731 | positive regulation of interleukin-1 beta production | 6.059658e-3 |
GO:0051301 | cell division | 6.077578e-3 |
GO:0060333 | interferon-gamma-mediated signaling pathway | 6.110270e-3 |
GO:0035305 | negative regulation of dephosphorylation | 6.128168e-3 |
GO:0071305 | cellular response to vitamin D | 6.129717e-3 |
GO:0032329 | serine transport | 6.185842e-3 |
GO:0043181 | vacuolar sequestering | 6.242835e-3 |
GO:0000023 | maltose metabolic process | 6.242835e-3 |
GO:0005985 | sucrose metabolic process | 6.242835e-3 |
GO:0009629 | response to gravity | 6.279069e-3 |
GO:0031958 | corticosteroid receptor signaling pathway | 6.304183e-3 |
GO:0031639 | plasminogen activation | 6.357867e-3 |
GO:0010070 | zygote asymmetric cell division | 6.477682e-3 |
GO:0033700 | phospholipid efflux | 6.522361e-3 |
GO:0050710 | negative regulation of cytokine secretion | 6.548097e-3 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 6.579732e-3 |
GO:0034097 | response to cytokine stimulus | 6.616780e-3 |
GO:0021516 | dorsal spinal cord development | 6.641673e-3 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 6.695324e-3 |
GO:0051386 | regulation of nerve growth factor receptor signaling pathway | 6.720802e-3 |
GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process | 6.775074e-3 |
GO:0001661 | conditioned taste aversion | 6.775074e-3 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 6.811766e-3 |
GO:0061015 | snRNA import into nucleus | 6.827390e-3 |
GO:0050973 | detection of mechanical stimulus involved in equilibrioception | 6.827390e-3 |
GO:0006430 | lysyl-tRNA aminoacylation | 6.827390e-3 |
GO:0045645 | positive regulation of eosinophil differentiation | 6.827390e-3 |
GO:0048822 | enucleate erythrocyte development | 6.827390e-3 |
GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase | 6.875012e-3 |
GO:2000366 | positive regulation of STAT protein import into nucleus | 6.948102e-3 |
GO:0070091 | glucagon secretion | 6.948102e-3 |
GO:0051385 | response to mineralocorticoid stimulus | 7.053680e-3 |
GO:0048820 | hair follicle maturation | 7.074015e-3 |
GO:0060311 | negative regulation of elastin catabolic process | 7.078883e-3 |
GO:0060313 | negative regulation of blood vessel remodeling | 7.078883e-3 |
GO:0010711 | negative regulation of collagen catabolic process | 7.078883e-3 |
GO:0010703 | negative regulation of histolysis | 7.078883e-3 |
GO:0034382 | chylomicron remnant clearance | 7.164413e-3 |
GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 7.200697e-3 |
GO:0046677 | response to antibiotic | 7.202759e-3 |
GO:0046599 | regulation of centriole replication | 7.267959e-3 |
GO:0060976 | coronary vasculature development | 7.271181e-3 |
GO:0032388 | positive regulation of intracellular transport | 7.432582e-3 |
GO:0050917 | sensory perception of umami taste | 7.443210e-3 |
GO:0003151 | outflow tract morphogenesis | 7.443228e-3 |
GO:0071577 | zinc ion transmembrane transport | 7.468839e-3 |
GO:0034763 | negative regulation of transmembrane transport | 7.498075e-3 |
GO:0060621 | negative regulation of cholesterol import | 7.507009e-3 |
GO:0051325 | interphase | 7.575036e-3 |
GO:0070562 | regulation of vitamin D receptor signaling pathway | 7.620296e-3 |
GO:0044237 | cellular metabolic process | 7.722822e-3 |
GO:0042640 | anagen | 7.723827e-3 |
GO:0017121 | phospholipid scrambling | 7.738647e-3 |
GO:0031063 | regulation of histone deacetylation | 7.829649e-3 |
GO:0000724 | double-strand break repair via homologous recombination | 7.901104e-3 |
GO:0002313 | mature B cell differentiation involved in immune response | 7.978472e-3 |
GO:0030521 | androgen receptor signaling pathway | 7.990267e-3 |
GO:0046898 | response to cycloheximide | 8.031400e-3 |
GO:0007406 | negative regulation of neuroblast proliferation | 8.128539e-3 |
GO:0046496 | nicotinamide nucleotide metabolic process | 8.210268e-3 |
GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly | 8.217987e-3 |
GO:0032817 | regulation of natural killer cell proliferation | 8.243915e-3 |
GO:0045087 | innate immune response | 8.340929e-3 |
GO:0071480 | cellular response to gamma radiation | 8.494468e-3 |
GO:0046824 | positive regulation of nucleocytoplasmic transport | 8.508222e-3 |
GO:0071346 | cellular response to interferon-gamma | 8.584402e-3 |
GO:0032652 | regulation of interleukin-1 production | 8.623836e-3 |
GO:0018904 | organic ether metabolic process | 8.689552e-3 |
GO:0060395 | SMAD protein signal transduction | 8.713338e-3 |
GO:0071478 | cellular response to radiation | 8.878489e-3 |
GO:0090116 | C-5 methylation of cytosine | 8.886620e-3 |
GO:0035278 | negative regulation of translation involved in gene silencing by miRNA | 8.886620e-3 |
GO:0071407 | cellular response to organic cyclic compound | 8.902096e-3 |
GO:0006733 | oxidoreduction coenzyme metabolic process | 8.946194e-3 |
GO:0032328 | alanine transport | 9.070301e-3 |
GO:0045066 | regulatory T cell differentiation | 9.098235e-3 |
GO:0009586 | rhodopsin mediated phototransduction | 9.098235e-3 |
GO:0010885 | regulation of cholesterol storage | 9.116758e-3 |
GO:0030324 | lung development | 9.117359e-3 |
GO:0043441 | acetoacetic acid biosynthetic process | 9.126665e-3 |
GO:0021993 | initiation of neural tube closure | 9.126665e-3 |
GO:0008612 | peptidyl-lysine modification to hypusine | 9.222307e-3 |
GO:0021599 | abducens nerve formation | 9.244472e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0048240 | sperm capacitation | 4.531250e-9 |
GO:0046513 | ceramide biosynthetic process | 6.575016e-9 |
GO:0046709 | IDP catabolic process | 8.570484e-9 |
GO:0046032 | ADP catabolic process | 8.570484e-9 |
GO:0045736 | negative regulation of cyclin-dependent protein kinase activity | 1.953914e-8 |
GO:0019853 | L-ascorbic acid biosynthetic process | 2.716981e-8 |
GO:0046520 | sphingoid biosynthetic process | 4.025664e-8 |
GO:0002385 | mucosal immune response | 1.192561e-7 |
GO:0006082 | organic acid metabolic process | 1.908089e-7 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 2.019817e-7 |
GO:0002251 | organ or tissue specific immune response | 3.087543e-7 |
GO:0006684 | sphingomyelin metabolic process | 3.160563e-7 |
GO:0050428 | 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process | 3.214826e-7 |
GO:0044283 | small molecule biosynthetic process | 3.859380e-7 |
GO:0046394 | carboxylic acid biosynthetic process | 4.004641e-7 |
GO:0043086 | negative regulation of catalytic activity | 5.011923e-7 |
GO:0050848 | regulation of calcium-mediated signaling | 5.975603e-7 |
GO:0015876 | acetyl-CoA transport | 6.216385e-7 |
GO:0006686 | sphingomyelin biosynthetic process | 7.190433e-7 |
GO:0019852 | L-ascorbic acid metabolic process | 7.863680e-7 |
GO:0046112 | nucleobase biosynthetic process | 8.723722e-7 |
GO:0061084 | negative regulation of protein refolding | 9.004408e-7 |
GO:0006189 | 'de novo' IMP biosynthetic process | 9.958098e-7 |
GO:0002227 | innate immune response in mucosa | 1.293118e-6 |
GO:0042180 | cellular ketone metabolic process | 1.449693e-6 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 1.854604e-6 |
GO:0019752 | carboxylic acid metabolic process | 1.971726e-6 |
GO:0046121 | deoxyribonucleoside catabolic process | 2.431918e-6 |
GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 2.522956e-6 |
GO:0046381 | CMP-N-acetylneuraminate metabolic process | 2.739584e-6 |
GO:0048102 | autophagic cell death | 3.567620e-6 |
GO:2000688 | positive regulation of rubidium ion transmembrane transporter activity | 4.670611e-6 |
GO:2000682 | positive regulation of rubidium ion transport | 4.670611e-6 |
GO:0035826 | rubidium ion transport | 4.670611e-6 |
GO:0051030 | snRNA transport | 4.942602e-6 |
GO:0009134 | nucleoside diphosphate catabolic process | 5.238284e-6 |
GO:0019087 | transformation of host cell by virus | 6.835936e-6 |
GO:0000279 | M phase | 6.941689e-6 |
GO:0044003 | modification by symbiont of host morphology or physiology | 8.227025e-6 |
GO:0006801 | superoxide metabolic process | 8.364290e-6 |
GO:0006916 | anti-apoptosis | 8.412712e-6 |
GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 8.944857e-6 |
GO:0061113 | pancreas morphogenesis | 9.869959e-6 |
GO:0006825 | copper ion transport | 1.001754e-5 |
GO:0010466 | negative regulation of peptidase activity | 1.010160e-5 |
GO:0042743 | hydrogen peroxide metabolic process | 1.029692e-5 |
GO:0042996 | regulation of Golgi to plasma membrane protein transport | 1.060300e-5 |
GO:0051817 | modification of morphology or physiology of other organism involved in symbiotic interaction | 1.086741e-5 |
GO:0090362 | positive regulation of platelet-derived growth factor production | 1.090030e-5 |
GO:0090336 | positive regulation of brown fat cell differentiation | 1.090030e-5 |
GO:0090271 | positive regulation of fibroblast growth factor production | 1.090030e-5 |
GO:0010035 | response to inorganic substance | 1.140511e-5 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 1.170963e-5 |
GO:0090083 | regulation of inclusion body assembly | 1.366986e-5 |
GO:0035814 | negative regulation of renal sodium excretion | 1.366986e-5 |
GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 1.564986e-5 |
GO:0045401 | positive regulation of interleukin-3 biosynthetic process | 1.564986e-5 |
GO:0006054 | N-acetylneuraminate metabolic process | 1.582674e-5 |
GO:0006188 | IMP biosynthetic process | 1.719136e-5 |
GO:0006979 | response to oxidative stress | 1.985416e-5 |
GO:0044281 | small molecule metabolic process | 2.195934e-5 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 2.309961e-5 |
GO:0032074 | negative regulation of nuclease activity | 2.410282e-5 |
GO:0048285 | organelle fission | 2.479720e-5 |
GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 2.500158e-5 |
GO:0042364 | water-soluble vitamin biosynthetic process | 2.701863e-5 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 3.237211e-5 |
GO:0045444 | fat cell differentiation | 3.338006e-5 |
GO:0006302 | double-strand break repair | 3.535965e-5 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB cascade | 3.682239e-5 |
GO:0010038 | response to metal ion | 3.827972e-5 |
GO:0046689 | response to mercury ion | 3.856752e-5 |
GO:0006144 | purine base metabolic process | 4.135827e-5 |
GO:0019430 | removal of superoxide radicals | 4.197914e-5 |
GO:0032060 | bleb assembly | 4.462098e-5 |
GO:0030819 | positive regulation of cAMP biosynthetic process | 4.784571e-5 |
GO:0070587 | regulation of cell-cell adhesion involved in gastrulation | 4.963339e-5 |
GO:0034114 | regulation of heterotypic cell-cell adhesion | 4.963339e-5 |
GO:0022403 | cell cycle phase | 5.298330e-5 |
GO:0043624 | cellular protein complex disassembly | 5.492013e-5 |
GO:0046483 | heterocycle metabolic process | 6.099545e-5 |
GO:0032025 | response to cobalt ion | 6.560444e-5 |
GO:0043366 | beta selection | 6.894953e-5 |
GO:0048710 | regulation of astrocyte differentiation | 7.299228e-5 |
GO:0050850 | positive regulation of calcium-mediated signaling | 7.330510e-5 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 7.331043e-5 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 7.372831e-5 |
GO:0044092 | negative regulation of molecular function | 7.378989e-5 |
GO:0007067 | mitosis | 7.611208e-5 |
GO:0046415 | urate metabolic process | 7.875664e-5 |
GO:0033578 | protein glycosylation in Golgi | 8.801164e-5 |
GO:0000103 | sulfate assimilation | 8.853689e-5 |
GO:0006412 | translation | 9.009538e-5 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 9.286289e-5 |
GO:0009120 | deoxyribonucleoside metabolic process | 9.286289e-5 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 1.034365e-4 |
GO:0042703 | menstruation | 1.034365e-4 |
GO:0019101 | female somatic sex determination | 1.034365e-4 |
GO:0045428 | regulation of nitric oxide biosynthetic process | 1.051981e-4 |
GO:0032241 | positive regulation of nucleobase-containing compound transport | 1.130438e-4 |
GO:0006391 | transcription initiation from mitochondrial promoter | 1.130438e-4 |
GO:0019371 | cyclooxygenase pathway | 1.172712e-4 |
GO:0032495 | response to muramyl dipeptide | 1.176714e-4 |
GO:0000303 | response to superoxide | 1.195570e-4 |
GO:0006633 | fatty acid biosynthetic process | 1.245741e-4 |
GO:0002313 | mature B cell differentiation involved in immune response | 1.268828e-4 |
GO:0032645 | regulation of granulocyte macrophage colony-stimulating factor production | 1.271619e-4 |
GO:0046031 | ADP metabolic process | 1.372210e-4 |
GO:0034115 | negative regulation of heterotypic cell-cell adhesion | 1.411451e-4 |
GO:0006982 | response to lipid hydroperoxide | 1.441993e-4 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 1.461156e-4 |
GO:0032494 | response to peptidoglycan | 1.470317e-4 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 1.550962e-4 |
GO:0043241 | protein complex disassembly | 1.550962e-4 |
GO:0006882 | cellular zinc ion homeostasis | 1.569293e-4 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 1.665713e-4 |
GO:0032463 | negative regulation of protein homooligomerization | 1.670036e-4 |
GO:0060018 | astrocyte fate commitment | 1.749199e-4 |
GO:0000087 | M phase of mitotic cell cycle | 1.873604e-4 |
GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process | 1.876251e-4 |
GO:0015684 | ferrous iron transport | 1.948869e-4 |
GO:0050849 | negative regulation of calcium-mediated signaling | 1.991933e-4 |
GO:2000347 | positive regulation of hepatocyte proliferation | 2.024925e-4 |
GO:0006672 | ceramide metabolic process | 2.044415e-4 |
GO:0006214 | thymidine catabolic process | 2.146906e-4 |
GO:0051346 | negative regulation of hydrolase activity | 2.190747e-4 |
GO:0034623 | cellular macromolecular complex disassembly | 2.328582e-4 |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | 2.460593e-4 |
GO:0006408 | snRNA export from nucleus | 2.630816e-4 |
GO:0030521 | androgen receptor signaling pathway | 2.723538e-4 |
GO:0001920 | negative regulation of receptor recycling | 2.727953e-4 |
GO:0007254 | JNK cascade | 2.731833e-4 |
GO:2000522 | positive regulation of immunological synapse formation | 2.761082e-4 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 2.761082e-4 |
GO:0048213 | Golgi vesicle prefusion complex stabilization | 2.794795e-4 |
GO:0002312 | B cell activation involved in immune response | 2.856082e-4 |
GO:0031573 | intra-S DNA damage checkpoint | 2.932602e-4 |
GO:0038003 | opioid receptor signaling pathway | 2.973557e-4 |
GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep | 3.065261e-4 |
GO:0045116 | protein neddylation | 3.078364e-4 |
GO:0051348 | negative regulation of transferase activity | 3.087057e-4 |
GO:0072573 | tolerance induction to lipopolysaccharide | 3.140132e-4 |
GO:2000349 | negative regulation of CD40 signaling pathway | 3.140132e-4 |
GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 3.140132e-4 |
GO:0034148 | negative regulation of toll-like receptor 5 signaling pathway | 3.140132e-4 |
GO:0070429 | negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 3.140132e-4 |
GO:0002632 | negative regulation of granuloma formation | 3.140132e-4 |
GO:0007256 | activation of JNKK activity | 3.141997e-4 |
GO:0006534 | cysteine metabolic process | 3.141997e-4 |
GO:0055090 | acylglycerol homeostasis | 3.272123e-4 |
GO:0002335 | mature B cell differentiation | 3.406899e-4 |
GO:0033673 | negative regulation of kinase activity | 3.448829e-4 |
GO:0009566 | fertilization | 3.504193e-4 |
GO:0044273 | sulfur compound catabolic process | 3.530591e-4 |
GO:0055069 | zinc ion homeostasis | 3.546978e-4 |
GO:0002676 | regulation of chronic inflammatory response | 3.549003e-4 |
GO:0000041 | transition metal ion transport | 3.922560e-4 |
GO:0006207 | 'de novo' pyrimidine base biosynthetic process | 4.114174e-4 |
GO:0061072 | iris morphogenesis | 4.121655e-4 |
GO:0050873 | brown fat cell differentiation | 4.198269e-4 |
GO:0006833 | water transport | 4.208429e-4 |
GO:0030801 | positive regulation of cyclic nucleotide metabolic process | 4.339761e-4 |
GO:0045128 | negative regulation of reciprocal meiotic recombination | 4.508242e-4 |
GO:0006561 | proline biosynthetic process | 4.508242e-4 |
GO:0006311 | meiotic gene conversion | 4.508242e-4 |
GO:0000305 | response to oxygen radical | 4.566486e-4 |
GO:0032984 | macromolecular complex disassembly | 4.643050e-4 |
GO:0010520 | regulation of reciprocal meiotic recombination | 4.802392e-4 |
GO:0009113 | purine base biosynthetic process | 4.875974e-4 |
GO:0032720 | negative regulation of tumor necrosis factor production | 4.905514e-4 |
GO:0006414 | translational elongation | 5.049733e-4 |
GO:0006469 | negative regulation of protein kinase activity | 5.131500e-4 |
GO:0071361 | cellular response to ethanol | 5.137301e-4 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB cascade | 5.399344e-4 |
GO:0019836 | hemolysis by symbiont of host erythrocytes | 6.149814e-4 |
GO:0009956 | radial pattern formation | 6.204960e-4 |
GO:0006212 | uracil catabolic process | 6.375375e-4 |
GO:0030148 | sphingolipid biosynthetic process | 6.395567e-4 |
GO:0051586 | positive regulation of dopamine uptake | 6.805282e-4 |
GO:0035037 | sperm entry | 7.129495e-4 |
GO:0015842 | synaptic vesicle amine transport | 7.129495e-4 |
GO:0006767 | water-soluble vitamin metabolic process | 7.145667e-4 |
GO:0061077 | chaperone-mediated protein folding | 7.158843e-4 |
GO:0005978 | glycogen biosynthetic process | 7.320263e-4 |
GO:0042742 | defense response to bacterium | 7.426774e-4 |
GO:0046519 | sphingoid metabolic process | 7.491036e-4 |
GO:0000710 | meiotic mismatch repair | 7.582556e-4 |
GO:0048712 | negative regulation of astrocyte differentiation | 7.629144e-4 |
GO:0033865 | nucleoside bisphosphate metabolic process | 7.737795e-4 |
GO:0052547 | regulation of peptidase activity | 8.595573e-4 |
GO:0051707 | response to other organism | 8.723181e-4 |
GO:0045226 | extracellular polysaccharide biosynthetic process | 8.993990e-4 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 8.993990e-4 |
GO:0015809 | arginine transport | 9.621501e-4 |
GO:0007258 | JUN phosphorylation | 9.621501e-4 |
GO:0051584 | regulation of dopamine uptake | 9.634006e-4 |
GO:0015840 | urea transport | 9.634006e-4 |
GO:0070541 | response to platinum ion | 9.637572e-4 |
GO:0046500 | S-adenosylmethionine metabolic process | 9.637572e-4 |
GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 9.655659e-4 |
GO:0019438 | aromatic compound biosynthetic process | 9.661922e-4 |
GO:0009110 | vitamin biosynthetic process | 9.661922e-4 |
GO:0070432 | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 9.788173e-4 |
GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway | 9.788173e-4 |
GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 9.788173e-4 |
GO:0009112 | nucleobase metabolic process | 1.000734e-3 |
GO:0070574 | cadmium ion transmembrane transport | 1.009077e-3 |
GO:0051383 | kinetochore organization | 1.020073e-3 |
GO:0032225 | regulation of synaptic transmission, dopaminergic | 1.046422e-3 |
GO:0010665 | regulation of cardiac muscle cell apoptosis | 1.068451e-3 |
GO:0051225 | spindle assembly | 1.081372e-3 |
GO:0000724 | double-strand break repair via homologous recombination | 1.089184e-3 |
GO:0033692 | cellular polysaccharide biosynthetic process | 1.147777e-3 |
GO:0072521 | purine-containing compound metabolic process | 1.170219e-3 |
GO:0002315 | marginal zone B cell differentiation | 1.171696e-3 |
GO:0046467 | membrane lipid biosynthetic process | 1.174630e-3 |
GO:0051261 | protein depolymerization | 1.181106e-3 |
GO:0042640 | anagen | 1.201772e-3 |
GO:0006418 | tRNA aminoacylation for protein translation | 1.202014e-3 |
GO:0071312 | cellular response to alkaloid | 1.204570e-3 |
GO:0015074 | DNA integration | 1.204570e-3 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.213487e-3 |
GO:0046833 | positive regulation of RNA export from nucleus | 1.252875e-3 |
GO:0070535 | histone H2A K63-linked ubiquitination | 1.252875e-3 |
GO:0002418 | immune response to tumor cell | 1.252875e-3 |
GO:0045987 | positive regulation of smooth muscle contraction | 1.259898e-3 |
GO:0044062 | regulation of excretion | 1.261729e-3 |
GO:0051295 | establishment of meiotic spindle localization | 1.342943e-3 |
GO:0042044 | fluid transport | 1.421993e-3 |
GO:0042554 | superoxide anion generation | 1.434729e-3 |
GO:0018202 | peptidyl-histidine modification | 1.435962e-3 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 1.437696e-3 |
GO:0048936 | peripheral nervous system neuron axonogenesis | 1.439142e-3 |
GO:0060302 | negative regulation of cytokine activity | 1.439142e-3 |
GO:2000313 | regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation | 1.439142e-3 |
GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation | 1.439142e-3 |
GO:0045751 | negative regulation of Toll signaling pathway | 1.439142e-3 |
GO:0032790 | ribosome disassembly | 1.439142e-3 |
GO:0031119 | tRNA pseudouridine synthesis | 1.439142e-3 |
GO:0006780 | uroporphyrinogen III biosynthetic process | 1.439142e-3 |
GO:0032543 | mitochondrial translation | 1.439142e-3 |
GO:0006419 | alanyl-tRNA aminoacylation | 1.484677e-3 |
GO:0010042 | response to manganese ion | 1.489195e-3 |
GO:0019835 | cytolysis | 1.494328e-3 |
GO:0007019 | microtubule depolymerization | 1.498519e-3 |
GO:0031998 | regulation of fatty acid beta-oxidation | 1.536398e-3 |
GO:0048820 | hair follicle maturation | 1.538511e-3 |
GO:0009617 | response to bacterium | 1.637642e-3 |
GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.653668e-3 |
GO:0031100 | organ regeneration | 1.665301e-3 |
GO:0044249 | cellular biosynthetic process | 1.693795e-3 |
GO:0090307 | spindle assembly involved in mitosis | 1.748371e-3 |
GO:0010457 | centriole-centriole cohesion | 1.748371e-3 |
GO:0006026 | aminoglycan catabolic process | 1.811945e-3 |
GO:0060631 | regulation of meiosis I | 1.843206e-3 |
GO:0030641 | regulation of cellular pH | 1.848400e-3 |
GO:0007132 | meiotic metaphase I | 1.848941e-3 |
GO:0055085 | transmembrane transport | 1.886775e-3 |
GO:0007126 | meiosis | 1.893128e-3 |
GO:0000278 | mitotic cell cycle | 1.908666e-3 |
GO:0009311 | oligosaccharide metabolic process | 1.929129e-3 |
GO:0000725 | recombinational repair | 1.985782e-3 |
GO:0043066 | negative regulation of apoptosis | 2.093125e-3 |
GO:0090361 | regulation of platelet-derived growth factor production | 2.102679e-3 |
GO:0051533 | positive regulation of NFAT protein import into nucleus | 2.102679e-3 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 2.104989e-3 |
GO:0042416 | dopamine biosynthetic process | 2.122140e-3 |
GO:2000348 | regulation of CD40 signaling pathway | 2.152912e-3 |
GO:0071279 | cellular response to cobalt ion | 2.161724e-3 |
GO:0046724 | oxalic acid secretion | 2.161724e-3 |
GO:0010637 | negative regulation of mitochondrial fusion | 2.161724e-3 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 2.161724e-3 |
GO:0007159 | leukocyte cell-cell adhesion | 2.181271e-3 |
GO:0051704 | multi-organism process | 2.238289e-3 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 2.256535e-3 |
GO:0051297 | centrosome organization | 2.267615e-3 |
GO:0043968 | histone H2A acetylation | 2.276379e-3 |
GO:0050892 | intestinal absorption | 2.280312e-3 |
GO:0043069 | negative regulation of programmed cell death | 2.307461e-3 |
GO:0010739 | positive regulation of protein kinase A signaling cascade | 2.311522e-3 |
GO:0046512 | sphingosine biosynthetic process | 2.311522e-3 |
GO:0043306 | positive regulation of mast cell degranulation | 2.319327e-3 |
GO:0006667 | sphinganine metabolic process | 2.332983e-3 |
GO:0060730 | regulation of intestinal epithelial structure maintenance | 2.367977e-3 |
GO:0035883 | enteroendocrine cell differentiation | 2.367977e-3 |
GO:0010312 | detoxification of zinc ion | 2.367977e-3 |
GO:0002252 | immune effector process | 2.409180e-3 |
GO:0030004 | cellular monovalent inorganic cation homeostasis | 2.434381e-3 |
GO:0009259 | ribonucleotide metabolic process | 2.463871e-3 |
GO:0051301 | cell division | 2.482973e-3 |
GO:0090270 | regulation of fibroblast growth factor production | 2.498240e-3 |
GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep | 2.506680e-3 |
GO:0071705 | nitrogen compound transport | 2.589152e-3 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 2.605643e-3 |
GO:0032680 | regulation of tumor necrosis factor production | 2.671282e-3 |
GO:0021781 | glial cell fate commitment | 2.679145e-3 |
GO:0045604 | regulation of epidermal cell differentiation | 2.679145e-3 |
GO:0034139 | regulation of toll-like receptor 3 signaling pathway | 2.699047e-3 |
GO:0051788 | response to misfolded protein | 2.700687e-3 |
GO:0016052 | carbohydrate catabolic process | 2.708270e-3 |
GO:0031098 | stress-activated protein kinase signaling cascade | 2.713372e-3 |
GO:0009268 | response to pH | 2.734764e-3 |
GO:0046485 | ether lipid metabolic process | 2.749243e-3 |
GO:0070536 | protein K63-linked deubiquitination | 2.825720e-3 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 2.844035e-3 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 2.850695e-3 |
GO:0015820 | leucine transport | 2.882589e-3 |
GO:0044314 | protein K27-linked ubiquitination | 2.892934e-3 |
GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis | 2.898429e-3 |
GO:0061325 | cell proliferation involved in outflow tract morphogenesis | 2.898429e-3 |
GO:0009313 | oligosaccharide catabolic process | 2.915187e-3 |
GO:0007596 | blood coagulation | 2.917425e-3 |
GO:0010898 | positive regulation of triglyceride catabolic process | 3.016855e-3 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 3.083667e-3 |
GO:0051883 | killing of cells in other organism involved in symbiotic interaction | 3.100196e-3 |
GO:0009896 | positive regulation of catabolic process | 3.119686e-3 |
GO:0048708 | astrocyte differentiation | 3.137514e-3 |
GO:0050746 | regulation of lipoprotein metabolic process | 3.140841e-3 |
GO:0032897 | negative regulation of viral transcription | 3.169530e-3 |
GO:0015672 | monovalent inorganic cation transport | 3.239539e-3 |
GO:0051340 | regulation of ligase activity | 3.264855e-3 |
GO:0000272 | polysaccharide catabolic process | 3.275498e-3 |
GO:0009058 | biosynthetic process | 3.293327e-3 |
GO:0071918 | urea transmembrane transport | 3.318033e-3 |
GO:0060586 | multicellular organismal iron ion homeostasis | 3.318033e-3 |
GO:0019344 | cysteine biosynthetic process | 3.318033e-3 |
GO:0002074 | extraocular skeletal muscle development | 3.318033e-3 |
GO:0034021 | response to silicon dioxide | 3.371766e-3 |
GO:0048773 | erythrophore differentiation | 3.371766e-3 |
GO:0007624 | ultradian rhythm | 3.371766e-3 |
GO:0001315 | age-dependent response to reactive oxygen species | 3.371766e-3 |
GO:0002357 | defense response to tumor cell | 3.371766e-3 |
GO:0003069 | vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure | 3.371766e-3 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 3.405279e-3 |
GO:0031638 | zymogen activation | 3.425109e-3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 3.457255e-3 |
GO:0031915 | positive regulation of synaptic plasticity | 3.471920e-3 |
GO:0031640 | killing of cells of other organism | 3.476298e-3 |
GO:0021571 | rhombomere 5 development | 3.546819e-3 |
GO:0060379 | cardiac muscle cell myoblast differentiation | 3.547726e-3 |
GO:0018993 | somatic sex determination | 3.547726e-3 |
GO:0018095 | protein polyglutamylation | 3.547726e-3 |
GO:0046479 | glycosphingolipid catabolic process | 3.553685e-3 |
GO:0002369 | T cell cytokine production | 3.553685e-3 |
GO:0045732 | positive regulation of protein catabolic process | 3.562142e-3 |
GO:0070256 | negative regulation of mucus secretion | 3.579285e-3 |
GO:0035786 | protein complex oligomerization | 3.579285e-3 |
GO:0048627 | myoblast development | 3.579285e-3 |
GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep | 3.579285e-3 |
GO:0046502 | uroporphyrinogen III metabolic process | 3.579285e-3 |
GO:0006826 | iron ion transport | 3.595410e-3 |
GO:0051096 | positive regulation of helicase activity | 3.640091e-3 |
GO:0050665 | hydrogen peroxide biosynthetic process | 3.661279e-3 |
GO:0009117 | nucleotide metabolic process | 3.674511e-3 |
GO:0007599 | hemostasis | 3.728930e-3 |
GO:0008610 | lipid biosynthetic process | 3.733831e-3 |
GO:0006446 | regulation of translational initiation | 3.741821e-3 |
GO:0060548 | negative regulation of cell death | 3.788345e-3 |
GO:0010575 | positive regulation vascular endothelial growth factor production | 3.801836e-3 |
GO:0031056 | regulation of histone modification | 3.827237e-3 |
GO:0001922 | B-1 B cell homeostasis | 3.863661e-3 |
GO:0034614 | cellular response to reactive oxygen species | 3.871146e-3 |
GO:0010656 | negative regulation of muscle cell apoptosis | 3.891134e-3 |
GO:0033005 | positive regulation of mast cell activation | 3.950314e-3 |
GO:0046638 | positive regulation of alpha-beta T cell differentiation | 4.001240e-3 |
GO:0006413 | translational initiation | 4.039603e-3 |
GO:0051321 | meiotic cell cycle | 4.115134e-3 |
GO:0042886 | amide transport | 4.127970e-3 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4.165492e-3 |
GO:0042074 | cell migration involved in gastrulation | 4.168184e-3 |
GO:0034372 | very-low-density lipoprotein particle remodeling | 4.168184e-3 |
GO:0045600 | positive regulation of fat cell differentiation | 4.306330e-3 |
GO:0046533 | negative regulation of photoreceptor cell differentiation | 4.316421e-3 |
GO:0002367 | cytokine production involved in immune response | 4.325191e-3 |
GO:0035329 | hippo signaling cascade | 4.347489e-3 |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 4.349387e-3 |
GO:0051220 | cytoplasmic sequestering of protein | 4.353768e-3 |
GO:0046532 | regulation of photoreceptor cell differentiation | 4.353768e-3 |
GO:0044241 | lipid digestion | 4.468785e-3 |
GO:0050862 | positive regulation of T cell receptor signaling pathway | 4.473819e-3 |
GO:0015802 | basic amino acid transport | 4.500757e-3 |
GO:0033076 | isoquinoline alkaloid metabolic process | 4.519102e-3 |
GO:0052314 | phytoalexin metabolic process | 4.519102e-3 |
GO:0006783 | heme biosynthetic process | 4.543401e-3 |
GO:0003032 | detection of oxygen | 4.549879e-3 |
GO:0060555 | induction of necroptosis by extracellular signals | 4.549879e-3 |
GO:0002230 | positive regulation of defense response to virus by host | 4.549879e-3 |
GO:0006069 | ethanol oxidation | 4.614312e-3 |
GO:0006210 | thymine catabolic process | 4.614312e-3 |
GO:0001881 | receptor recycling | 4.614312e-3 |
GO:0002710 | negative regulation of T cell mediated immunity | 4.729579e-3 |
GO:0043302 | positive regulation of leukocyte degranulation | 4.793279e-3 |
GO:0006824 | cobalt ion transport | 4.793279e-3 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 4.793279e-3 |
GO:0072593 | reactive oxygen species metabolic process | 4.892806e-3 |
GO:0045588 | positive regulation of gamma-delta T cell differentiation | 4.896838e-3 |
GO:0051099 | positive regulation of binding | 4.897377e-3 |
GO:0060677 | ureteric bud elongation | 4.944000e-3 |
GO:0045682 | regulation of epidermis development | 5.014304e-3 |
GO:0032715 | negative regulation of interleukin-6 production | 5.021965e-3 |
GO:0034442 | regulation of lipoprotein oxidation | 5.084670e-3 |
GO:0044240 | multicellular organismal lipid catabolic process | 5.113551e-3 |
GO:0010765 | positive regulation of sodium ion transport | 5.113551e-3 |
GO:0046124 | purine deoxyribonucleoside catabolic process | 5.171470e-3 |
GO:0051382 | kinetochore assembly | 5.209316e-3 |
GO:0035881 | amacrine cell differentiation | 5.209316e-3 |
GO:0045162 | clustering of voltage-gated sodium channels | 5.257500e-3 |
GO:0019448 | L-cysteine catabolic process | 5.257500e-3 |
GO:0000096 | sulfur amino acid metabolic process | 5.336037e-3 |
GO:0045684 | positive regulation of epidermis development | 5.388099e-3 |
GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 5.389871e-3 |
GO:0010002 | cardioblast differentiation | 5.464580e-3 |
GO:2000345 | regulation of hepatocyte proliferation | 5.465816e-3 |
GO:0032069 | regulation of nuclease activity | 5.485474e-3 |
GO:0048034 | heme O biosynthetic process | 5.533972e-3 |
GO:0006649 | phospholipid transfer to membrane | 5.533972e-3 |
GO:0046148 | pigment biosynthetic process | 5.547766e-3 |
GO:0090005 | negative regulation of establishment of protein localization in plasma membrane | 5.588990e-3 |
GO:0071421 | manganese ion transmembrane transport | 5.632548e-3 |
GO:0034612 | response to tumor necrosis factor | 5.677948e-3 |
GO:0021612 | facial nerve structural organization | 5.691334e-3 |
GO:0050996 | positive regulation of lipid catabolic process | 5.718748e-3 |
GO:0061136 | regulation of proteasomal protein catabolic process | 5.796962e-3 |
GO:0035434 | copper ion transmembrane transport | 5.885912e-3 |
GO:0006167 | AMP biosynthetic process | 5.949480e-3 |
GO:0030224 | monocyte differentiation | 5.980782e-3 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 6.001025e-3 |
GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 6.010864e-3 |
GO:0045665 | negative regulation of neuron differentiation | 6.014715e-3 |
GO:0043900 | regulation of multi-organism process | 6.051347e-3 |
GO:0002440 | production of molecular mediator of immune response | 6.151063e-3 |
GO:0010660 | regulation of muscle cell apoptosis | 6.260889e-3 |
GO:0061010 | gall bladder development | 6.271941e-3 |
GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 6.283451e-3 |
GO:0006689 | ganglioside catabolic process | 6.283451e-3 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 6.283451e-3 |
GO:0043922 | negative regulation by host of viral transcription | 6.339532e-3 |
GO:0031532 | actin cytoskeleton reorganization | 6.377971e-3 |
GO:0048311 | mitochondrion distribution | 6.452761e-3 |
GO:0032606 | type I interferon production | 6.452761e-3 |
GO:0009607 | response to biotic stimulus | 6.580532e-3 |
GO:0018130 | heterocycle biosynthetic process | 6.750588e-3 |
GO:0006091 | generation of precursor metabolites and energy | 6.762976e-3 |
GO:0031023 | microtubule organizing center organization | 6.855469e-3 |
GO:0032411 | positive regulation of transporter activity | 6.857404e-3 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.872081e-3 |
GO:0006163 | purine nucleotide metabolic process | 6.874022e-3 |
GO:0045823 | positive regulation of heart contraction | 7.031172e-3 |
GO:0033622 | integrin activation | 7.061685e-3 |
GO:0051238 | sequestering of metal ion | 7.090093e-3 |
GO:0035372 | protein localization to microtubule | 7.090093e-3 |
GO:0006705 | mineralocorticoid biosynthetic process | 7.090093e-3 |
GO:0006027 | glycosaminoglycan catabolic process | 7.090093e-3 |
GO:0002832 | negative regulation of response to biotic stimulus | 7.137102e-3 |
GO:0051592 | response to calcium ion | 7.184151e-3 |
GO:0006635 | fatty acid beta-oxidation | 7.185996e-3 |
GO:2000736 | regulation of stem cell differentiation | 7.187444e-3 |
GO:0002861 | regulation of inflammatory response to antigenic stimulus | 7.302622e-3 |
GO:0060836 | lymphatic endothelial cell differentiation | 7.323326e-3 |
GO:0016557 | peroxisome membrane biogenesis | 7.338298e-3 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 7.393787e-3 |
GO:0000097 | sulfur amino acid biosynthetic process | 7.478755e-3 |
GO:0070265 | necrotic cell death | 7.478933e-3 |
GO:0072086 | specification of loop of Henle identity | 7.478933e-3 |
GO:0006379 | mRNA cleavage | 7.552873e-3 |
GO:0010977 | negative regulation of neuron projection development | 7.567815e-3 |
GO:0044058 | regulation of digestive system process | 7.608240e-3 |
GO:0051580 | regulation of neurotransmitter uptake | 7.640477e-3 |
GO:0061015 | snRNA import into nucleus | 7.808458e-3 |
GO:0046683 | response to organophosphorus | 7.808458e-3 |
GO:0046653 | tetrahydrofolate metabolic process | 7.888974e-3 |
GO:0006828 | manganese ion transport | 8.036474e-3 |
GO:0042176 | regulation of protein catabolic process | 8.155043e-3 |
GO:0071288 | cellular response to mercury ion | 8.224273e-3 |
GO:0033194 | response to hydroperoxide | 8.277323e-3 |
GO:0032462 | regulation of protein homooligomerization | 8.277323e-3 |
GO:0035813 | regulation of renal sodium excretion | 8.295717e-3 |
GO:0048711 | positive regulation of astrocyte differentiation | 8.348976e-3 |
GO:0015793 | glycerol transport | 8.372681e-3 |
GO:0051095 | regulation of helicase activity | 8.404268e-3 |
GO:0008206 | bile acid metabolic process | 8.474186e-3 |
GO:0070781 | response to biotin | 8.478096e-3 |
GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity | 8.478096e-3 |
GO:0032692 | negative regulation of interleukin-1 production | 8.498854e-3 |
GO:0030050 | vesicle transport along actin filament | 8.743041e-3 |
GO:0016973 | poly(A)+ mRNA export from nucleus | 8.743041e-3 |
GO:0048670 | regulation of collateral sprouting | 8.798184e-3 |
GO:0045636 | positive regulation of melanocyte differentiation | 8.798184e-3 |
GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 8.840309e-3 |
GO:0002426 | immunoglobulin production in mucosal tissue | 8.863166e-3 |
GO:0050882 | voluntary musculoskeletal movement | 8.919584e-3 |
GO:0033574 | response to testosterone stimulus | 9.083645e-3 |
GO:0051186 | cofactor metabolic process | 9.118157e-3 |
GO:0009084 | glutamine family amino acid biosynthetic process | 9.132756e-3 |
GO:0042753 | positive regulation of circadian rhythm | 9.170138e-3 |
GO:0031953 | negative regulation of protein autophosphorylation | 9.186349e-3 |
GO:0071702 | organic substance transport | 9.199102e-3 |
GO:0015849 | organic acid transport | 9.474516e-3 |
GO:0006732 | coenzyme metabolic process | 9.506251e-3 |
GO:0051313 | attachment of spindle microtubules to chromosome | 9.603212e-3 |